# Arbutus Biopharma Corp (ABUS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Arbutus Biopharma Corp's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ABUS/mda/fy2025/): filed 2026-03-23; accession 0001447028-26-000017 (https://www.sec.gov/Archives/edgar/data/1447028/000144702826000017/abus-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ABUS/mda/fy2024/): filed 2025-03-27; accession 0001447028-25-000083 (https://www.sec.gov/Archives/edgar/data/1447028/000144702825000083/abus-20241231.htm)
- [FY 2023 MD&A](/company/ABUS/mda/fy2023/): filed 2024-03-05; accession 0001447028-24-000035 (https://www.sec.gov/Archives/edgar/data/1447028/000144702824000035/abus-20231231.htm)
- [FY 2022 MD&A](/company/ABUS/mda/fy2022/): filed 2023-03-02; accession 0001447028-23-000018 (https://www.sec.gov/Archives/edgar/data/1447028/000144702823000018/abus-20221231.htm)
- [FY 2021 MD&A](/company/ABUS/mda/fy2021/): filed 2022-03-03; accession 0001447028-22-000019 (https://www.sec.gov/Archives/edgar/data/1447028/000144702822000019/abus-20211231.htm)

Back to /company/ABUS/